It is important for clinicians to stay abreast with the latest data coming out of trials and individually consult their hair loss patients accordingly on a case by case basis, says this expert.
Maximizing results and safety of aggressive resurfacing procedures requires painstaking postprocedural care, says Dallas-based plastic and reconstructive surgeon A. Jay Burns, M.D.
Unscrupulous skin lightening practices are becoming a problem in the United States, according to dermatologist Arianne Shadi Kourosh, M.D., MPH.
New York city cosmetic dermatologist Michele Green, M.D., says having a muscle stimulating device can boost a practice’s bottom line but that’s not a given.
Cosmetic physician Tahl Humes, D.O., offers recommendations for doctors who are considering investing in body toning devices.
How does an aesthetic practice decide whether to invest in body toning technologies? We asked several aesthetic physicians to share what they’ve learned about what differentiates the technologies and more.
Understanding differences among preparations and dilutions of botulinum toxin type A can improve clinical practice, according to industry experts.
Collective results from the SAKURA phase 3 clinical trial program investigating daxibotulinumtoxinA for injection for the treatment of moderate-to-severe glabellar lines show that the neuromodulator provides generally safe and long-lasting results.
It’s known that combination therapies can be used to create ideal treatment outcomes, but according to Dr. Suneel Chilukuri, results may also last longer than originally thought.
Dr. Brian Biesman sits down with Dermatology Times to talk about the important role surgery plays in eyelid rejuvenation.